Pfizer Inc (PFIZ34) — Cash Flow Reinvestment Rate
Pfizer Inc (PFIZ34) has a Cash Flow Reinvestment Rate of 3.80x as of June 2026, reinvesting R$3.17 Billion (capex R$533.00 Million plus investments R$2.64 Billion) from operating cash flow of R$835.00 Million. See how much free cash does Pfizer Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Pfizer Inc Cash Flow Reinvestment Rate (2014–2025)
Historical reinvestment intensity for Pfizer Inc across 12 annual periods. For the full cash flow conversion analysis, see PFIZ34 operating cash flow.
Annual Cash Flow Reinvestment Rate for Pfizer Inc (2014–2025)
Year-by-year capital reinvestment analysis for Pfizer Inc. See financial flexibility index of Pfizer Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (BRL) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.37x | R$4.36 Billion | R$11.71 Billion | R$2.63 Billion | ▼ -14.7% |
| 2024 | 0.44x | R$5.56 Billion | R$12.74 Billion | R$2.91 Billion | ▼ -82.2% |
| 2023 | 2.45x | R$29.56 Billion | R$12.04 Billion | R$3.86 Billion | ▲ +624.3% |
| 2022 | 0.34x | R$9.92 Billion | R$29.27 Billion | R$3.24 Billion | ▼ -50.3% |
| 2021 | 0.68x | R$22.23 Billion | R$32.58 Billion | R$2.71 Billion | ▲ +120.2% |
| 2020 | 0.31x | R$4.46 Billion | R$14.40 Billion | R$2.79 Billion | ▼ -67.2% |
| 2019 | 0.95x | R$11.90 Billion | R$12.59 Billion | R$2.59 Billion | ▲ +73.4% |
| 2018 | 0.55x | R$8.63 Billion | R$15.83 Billion | R$2.20 Billion | ▲ +107.7% |
| 2017 | 0.26x | R$4.41 Billion | R$16.80 Billion | R$2.22 Billion | ▼ -56.7% |
| 2016 | 0.61x | R$9.81 Billion | R$16.19 Billion | R$2.00 Billion | ▼ -44.5% |
| 2015 | 1.09x | R$16.04 Billion | R$14.69 Billion | R$1.40 Billion | ▲ +244.0% |
| 2014 | 0.32x | R$5.42 Billion | R$17.08 Billion | R$1.20 Billion | — |